⌘K

Login Start Free

Home/Filings/4/0001104659-21-133652

4//SEC Filing

Mann Brenda 4

Accession 0001104659-21-133652

CIK 0001372514other

View on SEC.gov Company Profile

Filed

Nov 2, 8:00 PM ET

Accepted

Nov 3, 4:16 PM ET

Size

4.7 KB

Accession

0001104659-21-133652

Insider Transaction Report

Form 4

Period: 2021-11-02

EYEGATE PHARMACEUTICALS INCEYEG

VP of Research & Development

Transactions

Tax Payment
Common Stock
2021-11-02$1.98/sh−62$123→ 15,136 total

Footnotes (1)

[F1]Sale of shares to cover taxes due on restricted stock that vested on 11/01/2021.

Documents

1 file

4
tm2131814-2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1

filerCIK 0001668858

Filing Metadata

Form type: 4
Filed: Nov 2, 8:00 PM ET
Accepted: Nov 3, 4:16 PM ET
Size: 4.7 KB

View on SEC.gov